# XORI Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xori

- Industry: Biotechnology
- Headquarters: Seattle, US
- Total disclosed funding: $4.4M
- Latest round: Series A (Jun 1, 2009)
- Investors on record: 7

## About

Based in Seattle, US, and founded in 2009, XORI Corporation is a biotechnology firm engaged in the development of a monoclonal antibody discovery and development platform. The company was founded by Dr. Nancy Maizels, the director of the Molecular Medicine programme and a professor in the Immunology and Biochemistry Departments at the University of Washington. Furthermore, XORI Corporation was formed by Accelerator Corporation, a VC-backed biotechnology development and investment company, making XORI the second start-up backed by Accelerator Corporation that was established from the intellectual property invented at the University of Washington.  

The company’s primary focus is the invention of a technology dedicated to the discovery and development of monoclonal antibodies (MAbs), and potential products developed with this technology are mainly for infectious diseases, immune disorders and cancer therapy. The technology imitates the natural maturation and selection of antibodies with an expanded diversity repertoire, which can lead to the rapid generation of therapeutics against difficult disease targets.

## Funding rounds

- Series A, Jun 1, 2009, $2.3M — Accelerator Life Science Partners
- Series A, May 14, 2009, $2.1M — ARCH Venture Partners, OVP Venture Partners, Alexandria Venture Investments, Amgen Ventures, WRF Capital, PPD, Inc., Accelerator Life Science Partners

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A
- OVP Venture Partners (https://capitalatlas.ai/funds/ovp-venture-partners) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series A
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Series A
- PPD, Inc. — Series A
- Accelerator Life Science Partners (https://capitalatlas.ai/funds/accelerator-life-science-partners) — Series A